Viridian Therapeutics Inc

NASDAQ: VRDN    
Share price (5/16/24): $14.63    
Market cap (5/16/24): $934 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 12 pages Fourth Amended and Restated Bylaws of Viridian Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.2
from 10-Q 10 pages Third Amended and Restated Bylaws of Viridian Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.1
from 8-K 11 pages Second Amended and Restated Bylaws of Viridian Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.2
from 10-Q 10 pages Amended and Restated Bylaws of Viridian Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.1
from 10-K 5 pages Second Restated Certificate of Incorporation of Viridian Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 10 pages Viridian Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K/A 2 pages Certificate of Amendment of Restated Certificate of Incorporation of Viridian Therapeutics, Inc
12/34/56
EX-3.3
from 8-K 11 pages Amended and Restated Bylaws of Viridian Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.2
from 8-K 4 pages Restated Certificate of Incorporation of Viridian Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Miragen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Miragen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Miragen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 13 pages Miragen Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.4
from 8-K 4 pages Certificate of Ownership and Merger Merging Miragen Therapeutics, Inc., a Delaware Corporation With and Into Signal Genetics, Inc., a Delaware Corporation
12/34/56
EX-3.3
from 8-K 1 page Amendment to Bylaws of Signal Genetics, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Signal Genetics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Signal Genetics, Inc
12/34/56
EX-3.3
from S-4 2 pages State of Delaware Secretary of State Division of Corporations Delivered 07:47 Am 11/04/2016 Filed 07:47 Am 11/04/2016 Sr 20166497152 - File Number 4910486 Certificate of Amendment of Certificate of Incorporation of Signal Genetics, Inc
12/34/56
EX-3.1
from 425 2 pages Certificate of Amendment of Certificate of Incorporation of Signal Genetics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Signal Genetics, Inc
12/34/56